Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
The detection of free-living H. influenzae in the airways of patients with COPD Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD Source: International Congress 2016 – Translational research in respiratory infections Year: 2016
Movement of Haemophilus influenzae types resistance isolated from sputum in patients with COPD in 2004 Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005
Haemophilus influenza related respiratory infections and hospital re-admissions Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015
Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
High mortality in COPD patients with isolation of aspergillus spp in bronchial secretions Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Induction of the TGF-beta pseudoreceptor BAMBI by nontypeable haemophilus influenzae (NTHi) and its impact on TGF-beta induced effects Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method Source: Annual Congress 2013 –COPD and infections Year: 2013
HI-164, an oral vaccine to non-typable haemophilus influenzae , reduces antibiotic use, respiratory exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Microbiology of non-CF bronchiectasis Source: Eur Respir Mon 2011; 52: 68-96 Year: 2011
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Bacterial infections in COPD Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013